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SNAP-25 is a SNARE protein implicated in exocytosis and in the negative modulation of voltage gated 
calcium channels. We have previously shown that GABAergic synapses, which express SNAP-25 at much lower 
levels relative to glutamatergic ones, are characterized by a higher calcium responsiveness to depolarization and are 
largely resistant to botulinum toxin A. We show here that silencing of SNAP-25 in glutamatergic neurons, a 
procedure which increases KCl-induced calcium elevations, confers these synapses with toxin resistance. Since it is 
known that calcium  reverts the efficacy of botulinum  A, we investigated whether the lower effectiveness of the 
toxin in inhibiting GABAergic vesicle cycling might be attributable to higher evoked calcium transients of 
inhibitory neurons. We demonstrate that either expression of SNAP-251-197 or BAPTA/AM treatment, both inhibiting 
calcium dynamics, facilitate block of GABAergic vesicle exocytosis upon toxin treatment. These data indicate that 




SNAP-25 belongs to the SNARE superfamily of membrane proteins that participate in synaptic vesicle 
(SV) exocytosis. It contributes two alpha-helices in the formation of the exocytotic fusion complex together with 
syntaxin-1 and synaptobrevin/VAMP [1, 2]. Besides acting as a fundamental component of the SNARE complex, 
SNAP-25 has been shown to negatively modulate voltage gated calcium channels in various overexpression systems 
[3, 4] and  in cultured hippocampal neurons [5, 6]. 
Botulinum neurotoxin A (BoNT/A)  is a protease specific for SNAP-25. Although the BoNT/A-generated 
fragment, SNAP-251-197 , retains the capabillity to form the exocytotic fusion complex [7, 8], SNAP-25 proteolysis 
by the toxin reduces the probability of vesicle fusion and inhibits neurotransmitter release. It has been previously 
shown that BoNT/A preferentially inhibits SV recycling at glutamatergic terminals and is more efficient in impairing 
the release of excitatory than inhibitory neurotransmitters [5, 9, 10, 11]. Lower susceptibility of GABAergic 
terminals to BoNT/A does not result from a defective toxin penetration, in line with the presence of the BoNT/A 
receptor SV2 in inhibitory neurons [11]. Notably the different susceptibility to BoNT/A of glutamatergic and 
GABAergic cells correlates with the levels of expression of the toxin substrate SNAP-25 in the two neuron types. 
Indeed, although most cultured GABAergic neurons use SNAP-25 for evoked exocytosis [12, 13, 14], they are 
characterized by lower levels of SNAP-25 as compared to glutamatergic terminals [5, 15, 16, 17] and become 
sensitive to BoNT/A upon exogenous expression of the protein [11]. Why BoNT/A is highly efficient in inhibiting 
vesicle cycling selectively in neurons expressing high levels of SNAP-25 is still to be defined. The clarification of 
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this point may have important implications, especially in consideration of the wide use of BoNT/A for the treatment 
of human diseases, and in view of its employment in CNS pathologies [18, 19, 20]. 
 
2. MATERIALS AND METHODS 
 
2.1 Hippocampal neuronal cultures 
 
  Primary cultures of rat hippocampal neurons were prepared from the hippocampi of 18 day-old fetuses as 
previously described [11]. Neurons were transfected using the calcium phosphate precipitation method. Silencing of 
SNAP-25 was achieved via transfection of a pSUPER construct provided by T. Galli (Paris, France) [5]. The cDNA 
for SNAP-251-197 and SNAP-251-180 were generously provided O. Rossetto (Padua, Italy). 
 
2.2 Exo-endocytotic assay 
 
BoNT/A was a kind gift of Prof. Eric Johnson, Madison Wisconsin, purified and stored as previously 
described [11]. Control or transfected cultures were exposed to 125 nM BoNT/A for 2 hours at 37°C, before being 
assayed for SV recycling with monoclonal antibodies directed against the intravesicular domain of synaptotagmin I 
(Syt-ecto Abs; clone 604.2, kind gift of Dr. R. Jahn, Gottingen) as previously described [11]. Cultures were 
counterstained with polyclonal antibodies directed against vGLUT-1 (1:300, Synaptic Systems),  vGAT (1:400–800; 
Synaptic Systems) or GAD (human sera recognizing GAD, kind gift of Dr. Solimena, Dresden). In a set of 
experiments recycling of GABAergic vesicles was evaluated using anti vGAT luminal antibodies (vGAT ecto, kind 
gift of Dr. H. Martens, Synaptic Systems). Cultures were co-stained with monoclonal anti-VGAT-N (Synaptic 
Systems). Images were acquired using Zeiss LSM 510 Meta confocal microscope and analyzed by Image J software. 
vGLUT positive recycling synapses, transfected with siRNA construct, were revealed by generating a binary mask 
of siRNA/vGLUT double-positive images. Total fluorescence (area per mean grey value) of Syt-ecto positive 
synapses expressing the siRNA construct, identified by the binary mask, were normalized to the total fluorescence of 
the corresponding v-GLUT staining. Syt-ecto/vGLUT fluorescence ratios of siRNA-transfected synapses were 
compared to those of non transfected vGLUT synapses. vGAT positive recycling synapses, transfected with SNAP-
25-HA fragments, were revealed by generating a binary mask of SNAP-25-HA/vGAT double-positive images. The 
number of Syt-ecto positive synapses expressing SNAP-25-HA, identified by the binary mask, was calculated. 
Synapses were scored as positive for Syt-ecto Ab internalization when the fluorescence intensity was at least 2.5 to 3 
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times higher compared with cultures exposed only to secondary antibodies. For BAPTA experiments, vGAT positive 
synapses were revealed by generating a binary mask of vGAT images. Total fluorescence (area per mean grey value) 
of GABAergic Syt-ecto synapses, identified by the binary mask, were normalized to the total fluorescence of v-GAT 
staining. At least 10 fields containing excitatory/inhibitory synapses were analyzed, in three independent 
experiments. Quantitative analysis of SNAP-25 downregulation and overexpression in hippocampal cultures 
transfected with SNAP-25/GFP or cotransfected with iSNAP25 – GFP was carried out with monoclonal antibodies 
directed against SNAP-25 (SMI81, Sternberger Monoclonals, Baltimore MD). Images were acquired using Zeiss 
LSM 510 Meta confocal microscope and analyzed by Image J-1.4.3.67 NIH software. SNAP-25 expression was 
measured as mean grey value in neuronal processes of transfected and non-transfected cells. 
 
2.4 Calcium measurements 
 
Cultures were loaded with the ratiometric calcium dye FURA-2/AM as previously described [5]. 
Polychrome IV (TILL Photonics, Grafelfing, Germany) was used as a light source. Fura-2 fluorescence images were 
collected with a PCO Super VGA SensiCam (Axon Instruments, Forest City, CA, USA) and analysed with 
TILLvision software. After excitation at 340 and 380 nm wavelengths, the emitted light was acquired at 505 nm at 
1–4 Hz. The ratio values in discrete areas of interest were calculated from sequences of images to obtain temporal 
analyses. Calcium concentrations were expressed as F340/380 fluorescence ratios. 
 
2.5 Statistical analysis 
 
Results are presented as means + S.E. Data were statistically compared using the Student’s t test by using 
Origin software (Origin Lab, Northampton). One asterisk means p< 0.05, two asterisks p<0.01. 
 
3. RESULTS   
 
3.1 Levels of SNAP-25 expression influence neuron sensitivity to BoNT/A 
 
We have previously shown that GABAergic SV exocytosis, monitored by antibodies to the intravesicular 
domain of synaptotagmin I (Syt-ecto), is highly resistant to BoNT/A [5, 11]. By monitoring GABAergic vesicle 
fusion with antibodies recognizing the C-terminus of the vesicular GABA transporter vGAT  (vGAT ecto) [21], we 
confirmed that the majority of GABAergic terminals, intoxicated with 125 nM BoNT/A, internalized vGAT ecto 
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antibodies upon exposure to 55 mM KCl for 4 min;  exocytosis was instead efficiently blocked by tetanus toxin (20 
nM, TeNT) which cleaves synaptobrevin/VAMP-2 (figure 1A). Conversely, BoNT/A treatment inhibited SV 
recycling at excitatory synapses, monitored by antibodies to the intravesicular domain of synaptotagmin I (Syt-ecto) 
(figure 1B). SNAP-25 overexpression in GABAergic terminals was reported to largely increase sensitivity to 
BoNT/A and prevent Syt-ecto internalization [11]. To complement this finding and confirm that the expression level 
of SNAP-25 is an important determinant in neuronal sensitivity to BoNT/A, we investigated the effect of reducing 
SNAP-25 expression in glutamatergic neurons by co-transfection of cDNA codifying nucleotides 321 to 339 of rat 
SNAP-25 together with GFP (siRNA sequence). SNAP-25 expression was reduced of about 60% at 1-2 days after 
transfection (figure 1C, quantitation) and progressively decreased to levels not reliably quantifiable (figure 1C, 
arrow). Downregulation of SNAP-25 did not impair Syt-ecto Abs internalization at excitatory terminals (figure 1D), 
thus implying that low levels of the protein are sufficient to mediate SV fusion, as already demonstrated in cultures 
derived from SNAP-25 heterozygous mice [13, F. Antonucci, I. Corradini, C. Verderio and M.Matteoli, unpublished 
observations]. Cultures co-transfected with SNAP-25 siRNA sequence and GFP were exposed to BoNT/A and SV 
recycling was assayed using Syt-ecto Abs. A larger resistance to BoNT/A was detected at SNAP-25-silenced 
excitatory synapses. Indeed,  the percentage of excitatory synapses resistant to intoxication raised from about 20% in 
controls to 40% after siRNA treatment (figure 1 E). Furthermore the extent of recycling in SNAP-25-silenced 
boutons was higher as compared to the BoNT/A resistant terminals, either non transfected or GFP transfected (figure 
1E and F). Overall these data support the concept that variations in the expression of the SNARE at nerve terminals 
underlie differences in BoNT/A sensitivity.  
 
3.2 Reduction of neuronal calcium transients enhances sensitivity of GABAergic terminals to BoNT/A  
 
BoNT/A cleaves SNAP-25 at residue 197 to generate a membrane bound NH2-terminal SNAP-251-197 
fragment, while BoNT/E removes a larger C terminus region of the protein by cleaving SNAP-25 at residue 180. 
The 17 amino acids between the cleavage sites for BoNT/A and BoNT/E  are known to be required for high affinity 
binding of SNAP-25 to syntaxin 1 [22], for ternary complex formation with VAMP-2 and syntaxin 1 [7], for Ca2+-
triggered membrane fusion [23] and Ca2+-dependent synaptotagmin binding [24]. In addition, the C-terminal  region 
of SNAP-25 between BoNT/A and BoNT/E cleavage sites is also required for SNAP-25 modulation of voltage 
gated calcium currents [5, 6].  
To get insights into the mechanisms by which overexpression of SNAP-25 confers GABAergic neurons 
with BoNT/A sensitivity [11], hippocampal cultures were transfected with plasmids encoding portions of SNAP-25 
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(SNAP-251-180 and SNAP-251-197) fused to a HA-tag. SV fusion was monitored in transfected GABAergic terminals 
upon BoNT/A intoxication.  While no significant reduction of SV exocytosis was detected at intoxicated GAD 
positive synapses expressing the SNAP-251-180 fragment, SV fusion was strongly impaired at GAD positive synapses 
expressing SNAP-251-197 (figure 2A-C). SV recycling was only analyzed at terminals where the expression levels of 
the transfected fragment was increased of about 2 folds, excluding those terminals expressing higher protein 
amounts (3-8 folds, figure 2C). This effect was not due to an inhibitory action of SNAP-251-197 fragment on SV 
fusion, since exogenous expression of the fragment in inhibitory neurons did not impair vesicle recycling (figure 
2D). These results indicate that SNAP-251-197, but not SNAP-251-180 is able to enhance GABAergic neuron 
sensitivity to BoNT/A, similarly to full length SNAP-25 [11] .  
It has been previously shown that  BoNT/A-inhibition of SV fusion can be overcome by high calcium 
concentrations [25, 26, 27]. Based on this finding, Delgado-Martinez et al. [12] suggested that the lower efficacy of 
BoNT/A in inhibiting GABAergic vesicle cycling might be attributable to the higher calcium responsiveness of 
GABAergic relative to glutamatergic neurons. Given  SNAP-251-197 but not SNAP-251-180 negatively modulates 
evoked calcium responses [5], the possibility opens that SNAP-251-197,  as the full length protein, enhances BoNT/A 
sensitivity by reducing calcium currents. To directly address this hypothesis, cultures were treated with the 
membrane permeable calcium chelator BAPTA/AM (25 μM) for 15 or 20 min. BAPTA/AM incubation for 15 min 
reduced by about 30% peak calcium transients evoked by 55 mM KCl (figure 3A, B) and only mildly affected 
depolarization-induced SV fusion at GABAergic synapses (fig. 3C-D). Of note, BAPTA/AM largely increased the 
sensitivity of GABAergic terminals to BoNT/A (figure 3 E and F). Although monitoring of Ca2+ elevation was 
carried out in neuronal cell bodies, these data suggest that the higher [Ca2+]i responses at GABAergic terminals can 




Given that BoNTs do not cross the blood–brain barrier, their action is normally limited to peripheral nerve terminals. 
However, when injected directly into the brain, BoNTs can intoxicate neurons of the central nervous tissue, which 
express both substrates and receptors of BoNTs, with specific patterns of distribution. The preferential expression of 
receptors/substrates at specific neurons might underlie the preferential efficiency of BoNTs at selected terminals 
[20]. In the case of BoNT/A, however, the different sensitivity of glutamatergic and GABAergic neurons to the 
toxin does not result from receptor expression [11]. It does not result either from the presence in GABAergic 
neurons of  a BoNT/A-resistant substrate, such as SNAP-47 or SNAP-29, since SNAP-25 has been shown to 
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mediate GABA release in primary cultures [12, 13, 14].  Here we show that two treatments which reduce evoked 
calcium transients, ie transfection of SNAP-25 1-197  and exposure to BAPTA-AM, increase susceptibility of 
GABaergic neurons to BoNT/A. Conversely, downregulation of SNAP-25, which increases  evoked calcium 
transients [5], makes glutamatergic neurons more resistant to BoNT/A. These data suggest that susceptibility of 
neurons to BoNT/A results from the intrinsic calcium responsiveness to depolarization, which, among different 
factors, is modulated by the level of expression of SNAP-25 [5, 6, 28]. Interestingly, different intracellular 
calcium dynamics do not affect toxin penetration [11]. Our data are consistent with previous evidences obtained 
in hippocampal slice cultures, where significant increases in mEPSC frequency were produced in BoNT/A-treated 
cultures by application of the Ca2+ ionophore ionomycin in the presence of 10 mM [Ca2+] [25].  Similarly,  
elevating calcium concentration  at the calyx of Held with the use of caged calcium, produced a strong reduction in 
the calcium sensitivity for release after the cleavage of SNAP-25 by BoNT/A [27]. Interestingly, besides the 
amplitude of the peak calcium transients, also the temporal pattern of depolarization-induced calcium elevations 
influences neuronal BoNT/A susceptibility. Indeed, BoNT/A  has been reported to abolish CGRP release induced by 
high KCl or bradykinin in trigeminal ganglionic neurons, but not that induced by capsaicin, which evokes a more 
prolonged calcium response as compared to the other stimuli [8]. Under this respect, it is of note that GABAergic 
neurons display not only  higher but also slowly inactivating calcium currents compared to glutamatergic neurons 
(S. Condliffe, I. Corradini , D. Pozzi, C.Verderio and M. Matteoli, unpublished results). Altogether these data 
indicate that, in addition to receptor and/or substrate expression, a different susceptibility to BoNT/A may also result 
from intrinsic calcium dynamics in distinct neuronal populations. These data add a relevant information for the use 
of BoNT/A in the therapy of neurological disorders caused by the unbalanced activity of excitatory neuronal 
populations where maintenance of GABAergic transmission could be advantageous. Among these disorders are 
epilepsy [19] and  neuropathic pain [29].  
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FIGURE LEGENDS  
Figure 1 Downregulation of SNAP-25 at glutamatergic synapses reduces BoNT/A sensitivity  
A, B Uptake of  vGAT ecto (A, green) or Syt ecto Abs (B, red) at inhibitory terminals stimulated with 55 mM KCl 
in control neurons or in neurons intoxicated with BoNT/A or TeNT. Internalized antibodies were visualized after 
fixation and permeabilization by indirect immunofluorescence. Neurons were counterstained for vGAT-N (A, red) 
or vGLUT-1 (B, green). C, SNAP-25 immunoreactivity (red) at vGLUT-1 positive glutamatergic synapses (blue),  
co-transfected with SNAP-25 siRNA construct and GFP (green), 4-5 days after transfection. Arrow indicates a 
transfected glutamatergic synapse, virtually devoid of SNAP-25. The histogram shows mean gray value  detected in 
neuronal processes of non transfected and siRNA transfected neurons, 1-2 days after  transfection. D, Cultures 
transfected with SNAP-25 siRNA construct and GFP (green) were incubated with Syt-ecto Ab (red) under 
depolarizing conditions and counterstained with antibodies anti-vGLUT-1 (blue). E, In BoNT/A-intoxicated cultures 
the Syt-ecto Abs are more efficiently internalized at SNAP-25 siRNA and GFP co-transfected synapses than at 
control synapses. F, Histogram shows the quantitative analysis of  SV recycling at siRNA  GFP co-transfected 
(SNAP-25 siRNA), non transfected (control) or GFP transfected (GFP) glutamatergic synapses .Scale bar: 4 μm in 
A, B and E; 5 μm in C and D. 
Figure 2 Expression of  SNAP-25 1-197 but not SNAP-25 1-180 enhances sensitivity of  GABAergic synapses to 
BoNT/A  
A and B, Cultures transfected with SNAP-25 1-197 or SNAP-25 1-180 fused to a HA tag (red) were intoxicated with 
BoNT/A, incubated with Syt-ecto Abs (blue) and counterstained with antibodies against GAD (green). While 
SNAP-25 1-180 expression does not significantly alter SV recycling, SNAP-25 1-197 confers GABAergic synapses 
with BoNT/A sensitivity. C, Quantitative analysis of SNAP-25 1-197 overexpression (mean gray value) in transfected 
processes as compared to non transfected ones. Neurons characterized by an expression ratios exceeding three-fold 
were discarded from the analysis of SV recycling shown in D.  D, Quantitative analysis of  SV recycling at SNAP-
25 1-197 or SNAP-25 1-180  transfected GABAergic synapses as compared to non transfected ones. E, Cultures 
transfected with SNAP-25 1-197 fused to a HA tag (green) were incubated with Syt-ecto Abs (red) under depolarizing 
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conditions and counterstained with antibodies against GAD (blue). Note that Syt-ecto Abs are efficiently 
internalized in GABAergic processes expressing SNAP-25 1- 197 (see also inset). Number of analyzed interneurons 
expressing SNAP-25 1-197 =33; number of GFP transfected interneurons =40; number of experiments: 5.Scale bar: 8 
μm in A,  7 μm inset; 8 μm in B; 9 μmin D, 4 μm inset.  
Figure 3 BAPTA-AM treatment enhances sensitivity of  GABAergic synapses to BoNT/A  
A, Temporal analysis of calcium transients induced in FURA-2 loaded neurons by 55 mM KCl before and after 
incubation with BAPTA-AM. Calcium concentrations are indicated as 340/380 fluorescence ratios. B, Quantitative 
analysis of calcium transient amplitude after BAPTA-AM treatment for 15 or 20 min. C, D, Uptake of Syt ecto Abs 
(red) at vGAT positive inhibitory terminals (green) in control or BAPTA-AM- treated cultures (15 min). 
Quantitative analysis of Syt ecto Abs internalization is shown in D. E and F, Uptake of Syt ecto Abs (red) at vGAT 
positive synapses (green) in BoNT/A intoxicated cultures incubated or not with BAPTA-AM. Note that GABAergic 
vesicle fusion is more efficiently inhibited by BoNT/A in cultures exposed to BAPTA-AM (F) Scale bar: 10 μm in 
C, 8 μm in E. 
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